Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001866488 | SCV002122707 | uncertain significance | Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome | 2022-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 46 of the COQ4 protein (p.Pro46Arg). This variant is present in population databases (rs566983104, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with COQ4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1354567). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001866488 | SCV002814229 | uncertain significance | Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome | 2021-07-02 | criteria provided, single submitter | clinical testing |